<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A metabolic hypothesis is presented for <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in <z:hpo ids='HP_0001513'>obesity</z:hpo>, in the presence or absence of Type 2 (non-insulin-dependent) <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>It is based on physiological mechanisms including a series of negative feed-back mechanisms, with the inhibition of the function of the <z:chebi fb="15" ids="28087">glycogen</z:chebi> cycle in skeletal muscle as a consequence of decreased <z:chebi fb="105" ids="17234">glucose</z:chebi> utilization resulting from increased <z:chebi fb="23" ids="18059">lipid</z:chebi> oxidation in the <z:mp ids='MP_0001261'>obese</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>It considers the inhibition of <z:chebi fb="15" ids="28087">glycogen</z:chebi> synthase activity together with inhibition of <z:chebi fb="105" ids="17234">glucose</z:chebi> storage and <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The prolonged duration of increased <z:chebi fb="23" ids="18059">lipid</z:chebi> oxidation, considered as the initial cause, may lead to Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>This hypothesis is compatible with others based on the inhibition of insulin receptor kinase and of <z:chebi fb="105" ids="17234">glucose</z:chebi> transporter activities </plain></SENT>
</text></document>